101 related articles for article (PubMed ID: 11724751)
1. In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA.
Cannon DM; Keenan AK; Guiry PJ; Buon C; Baird AW; McBean GJ
Br J Pharmacol; 2001 Dec; 134(7):1455-60. PubMed ID: 11724751
[TBL] [Abstract][Full Text] [Related]
2. Blockade of noradrenaline transport abolishes 4-methylthioamphetamine-induced contraction of the rat aorta in vitro.
Quinn ST; Guiry PJ; Schwab T; Keenan AK; McBean GJ
Auton Autacoid Pharmacol; 2006 Oct; 26(4):335-44. PubMed ID: 16968472
[TBL] [Abstract][Full Text] [Related]
3. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
[TBL] [Abstract][Full Text] [Related]
4. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
5. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
6. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
Commins DL; Vosmer G; Virus RM; Woolverton WL; Schuster CR; Seiden LS
J Pharmacol Exp Ther; 1987 Apr; 241(1):338-45. PubMed ID: 2883295
[TBL] [Abstract][Full Text] [Related]
8. In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine.
Murphy J; Flynn JJ; Cannon DM; Guiry PJ; McCormack P; Baird AW; McBean GJ; Keenan AK
Eur J Pharmacol; 2002 May; 444(1-2):61-7. PubMed ID: 12191583
[TBL] [Abstract][Full Text] [Related]
9. Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats.
Thompson MR; Callaghan PD; Hunt GE; McGregor IS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1013-21. PubMed ID: 18302974
[TBL] [Abstract][Full Text] [Related]
10. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations.
Sabol KE; Lew R; Richards JB; Vosmer GL; Seiden LS
J Pharmacol Exp Ther; 1996 Feb; 276(2):846-54. PubMed ID: 8632358
[TBL] [Abstract][Full Text] [Related]
11. Effect of acute and chronic tramadol on [3H]-5-HT uptake in rat cortical synaptosomes.
Giusti P; Buriani A; Cima L; Lipartiti M
Br J Pharmacol; 1997 Sep; 122(2):302-6. PubMed ID: 9313939
[TBL] [Abstract][Full Text] [Related]
12. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
[TBL] [Abstract][Full Text] [Related]
13. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
[TBL] [Abstract][Full Text] [Related]
14. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
[TBL] [Abstract][Full Text] [Related]
15. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.
Sanchez V; Camarero J; Esteban B; Peter MJ; Green AR; Colado MI
Br J Pharmacol; 2001 Sep; 134(1):46-57. PubMed ID: 11522596
[TBL] [Abstract][Full Text] [Related]
16. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
[TBL] [Abstract][Full Text] [Related]
17. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
Sprague JE; Nichols DE
J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579
[TBL] [Abstract][Full Text] [Related]
18. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices.
Iravani MM; Asari D; Patel J; Wieczorek WJ; Kruk ZL
Synapse; 2000 Jun; 36(4):275-85. PubMed ID: 10819905
[TBL] [Abstract][Full Text] [Related]
19. [A preliminary study on the mechanism of neurotoxicity of MDMA--oxidative stress harm].
Li SX; Sun AM; Wang X; Li J; Peng ZG; Kuang WH; Huang MS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):191-5. PubMed ID: 16608072
[TBL] [Abstract][Full Text] [Related]
20. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
Callaway CW; Wing LL; Geyer MA
J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
